1 / 7

Monoclonal Antibodies Market Statistics 2021 | Trend & Growth Forecast To 2027

The rising occurrence of diseases like cancer, has majorly contributed to the demand for monoclonal antibodies market forecast. Estimates by WHO suggested that cancer caused over 10 million deaths in 2020. <br><br>Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5065

11788
Download Presentation

Monoclonal Antibodies Market Statistics 2021 | Trend & Growth Forecast To 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Monoclonal Antibodies Market is projected to reach CAGR 13.8% by 2027

  2. Key Insights from Monoclonal Antibodies Market: • The rising occurrence of diseases like cancer, has majorly contributed to the demand for monoclonal antibodies market forecast. Estimates by WHO suggested that cancer caused over 10 million deaths in 2020. • As a result of this, industry players are highly involved in research & development activities for producing drugs based on monoclonal antibodies. As of May 2021, a 3rd phase study of anti-PD-L1 monoclonal antibody-Sugemalimab concluded that the antibody can be considered as a complete therapy for treating stage-3 non-small cell lung cancer. Owing to this, the adoption of monoclonal antibodies (mAbs) is touted to increase in the years to come. • Amongst all the types of monoclonal antibodies, the chimeric ones are easily produced using recombinant technology. Chimeric antibodies possess high specificity, owing to which they are utilized in precision medicine for targeting specific diseases. In fact, they are prominently used for treating blood cancers and autoimmune disorders. Given these benefits, chimeric antibodies market is projected to record phenomenal proceeds in the years to come.

  3. Regional Insights in Monoclonal Antibodies Market: • On the regional front, the Asia Pacific is forecasted to proliferate at a CAGR of 15% through 2027. Developing countries, like India, boast of well-equipped facilities for manufacturing pharmaceutical and biopharmaceutical drugs. This works well for increasing the adoption of monoclonal antibodies as India has a high rate of approving antibody-laced products. In addition, China has devised its drug approval and regulatory policies to stay on track with markets of western countries, thereby increasing the adoption of monoclonal antibodies.

  4. Latest Research Report On Monoclonal Antibodies Market @ https://www.gminsights.com/industry-analysis/monoclonal-antibodies-market Request for a sample of this research report @https://www.gminsights.com/request-sample/detail/5065

  5. Major Companies in Monoclonal Antibodies Market: • AbbVie Inc. • F. Hoffmann-La Roche • Bristol • Myers Squibb • Amgen • Novartis AG

  6. Industry Coverage

  7. Stay In Touch Website: www.gminsights.com Social Media:

More Related